AI Article Synopsis

  • The study explores the link between migraine with aura (MWA) and cerebral small-vessel disease (CSVD) in young adults who experienced their first ischemic stroke.
  • Out of 646 patients, those with MWA showed a lower frequency of potentially causal CSVD lesions compared to non-migraine patients, but this disappeared after adjusting for vascular risk factors.
  • The findings suggest that MWA may not have a significant association with CSVD as a cause of stroke in this population.

Article Abstract

Background: Migraine with aura (MWA) is a risk factor for stroke, but the mechanisms underlying this association remain unclear. Our aim was to assess the association between MWA and cerebral small-vessel disease (CSVD) ischemic stroke after adjustment for vascular risk factors in a population of young patients hospitalized for a first-ever ischemic stroke.

Methods: Patients aged 18-54 years consecutively hospitalized for a first-ever acute ischemic stroke at the neurovascular unit of our university hospital between January 2017 and July 2021 were included in this retrospective cohort study. CSVD lesions were assessed and classified according to ASCOD (Atherosclerosis, Small-Vessel Disease, Cardiac pathology, Others causes, Dissection) classification criteria.

Results: In total, 646 patients were included (median (SD) age, 44.03 (9.01) years; 61.8% male) including 115 patients with MWA and 110 patients with migraine without aura (MWoA). Grade S1, potentially causal, CSVD lesions were significantly less frequent in patients with MWA (odds ratio (OR) = 0.35, 95% cofdence interval (CI)  =  0.13-0.95,  = 0.048) compared to non-migraine patients in univariate analysis. Logistic regression adjusting for vascular risk factors showed no significant association of CSVD of any grade (S1, S2 or S3 vs. S0) with migraine: OR = 0.78, 95% CI = 0.48-1.28,  = 0.34; MWoA: OR = 0.81, 95% CI = 0.42-1.47,  = 0.51; and MWA: OR = 0.84, 95% CI = 0.43-1.56,  = 0.60, as well as no association of grade S1 CSVD lesions with migraine: OR = 0.91, 95% CI = 0.40-1.92,  = 0.81; MWoA: OR = 1.11, 95% CI = 0.42-2.64,  = 0.81; and MWA: OR = 0.72, 95% CI = 0.20-1.98,  = 0.56.

Conclusions: In a retrospective study including almost 650 young adults hospitalized for a first ischemic stroke, MWA was not associated with CSVD cause of stroke after adjustment for vascular risk factors.

Download full-text PDF

Source
http://dx.doi.org/10.1177/03331024241282015DOI Listing

Publication Analysis

Top Keywords

ischemic stroke
16
small-vessel disease
12
vascular risk
12
risk factors
12
csvd lesions
12
migraine aura
8
stroke adjustment
8
adjustment vascular
8
hospitalized first-ever
8
patients mwa
8

Similar Publications

Background: The obesity paradox refers to lower mortality rates among overweight or obese individuals within certain populations. However, whether this paradox is applicable to patients undergoing percutaneous coronary intervention (PCI) remains unclear.

Methods: A total of 5,427 patients with coronary artery disease (CAD) who underwent successful PCI between 2005 and 2015 were enrolled.

View Article and Find Full Text PDF

Tandem occlusion due to acute cervical carotid artery dissection should be promptly treated with thrombectomy for reperfusion. If the cervical lesion has reached severe stenosis or complete occlusion, balloon angioplasty and, in certain cases, carotid artery stenting should be performed before thrombectomy for the intracranial lesion. Angioplasty or stent placement is performed in the true lumen, but securing the placement is challenging when the true lumen cannot be determined.

View Article and Find Full Text PDF

L. protects cerebral ischemia/reperfusion injury via arachidonic acid/p53-mediated apoptosis axis.

Front Pharmacol

December 2024

State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.

Introduction: Stroke is a debilitating disease and the second leading cause of death worldwide, of which ischemic stroke is the dominant type. L., also known as safflower, has been used to treat cerebrovascular diseases, especially ischemic stroke in many Asian countries.

View Article and Find Full Text PDF

Background: Salvianolic acid B (Sal B) is potentially the most valuable water-soluble active component in Salvia miltiorrhiza. Its chemical formula contains multiple phenolic hydroxyl groups, so it has a strong antioxidant capacity.

Objective: We aim to investigate the efficacy and the potential mechanism of Sal B in the treatment of acute ischemic stroke injury.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!